Interleukin-6 induced at mucosal surfaces by gram-negative bacterial infection.
AUTOR(ES)
de Man, P
RESUMO
Interleukin-6 (IL-6) was produced in response to mucosal and systemic infection of mice with gram-negative bacteria. The IL-6 response was controlled by the lipopolysaccharide gene, Lps; in C3H/HeN mice (Lpsn/Lpsn), the urinary IL-6 levels increased within 30 min after challenge with Escherichia coli, but no response occurred in C3H/HeJ mice (Lpsd/Lpsd). In lipopolysaccharide-responder mice, the levels of local and systemic IL-6 were related to the degree of infection. The urinary response dominated after intravesical challenge, and the serum response dominated after intraperitoneal challenge. The results demonstrate that IL-6 is activated as part of lipopolysaccharide-induced mucosal and systemic responses to gram-negative bacterial infections.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=259830Documentos Relacionados
- Interleukin-8 and the neutrophil response to mucosal gram-negative infection.
- Interleukin-6 response to deliberate colonization of the human urinary tract with gram-negative bacteria.
- Effects of anti-inflammatory agents on mucosal inflammation induced by infection with gram-negative bacteria.
- A low dose of recombinant interleukin 1 protects granulocytopenic mice from lethal gram-negative infection.
- Recombinant interleukin-6 protects mice against experimental bacterial infection.
